Prevalence of Abuse Among Patients With Rheumatic Diseases

Status Recruiting

Clinical Trial Summary

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes. Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability. The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.

Clinical Trial Description

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes. In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights violation. In 2012 Giraldo-Rodríguez developed and validated the Geriatric Abuse Scale (GAS), an instrument that, with adequate psychometric properties, reported a prevalence of abuse of 10.28% in Mexico. Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability. The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06233760
Study type	Observational
Source	National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Contact	Virginia Ph Pascual-Ramos
Phone	525555734111
Email	virtichu@gmail.com
Status	Recruiting
Phase
Start date	April 1, 2023
Completion date	March 2, 2026

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04976972` - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation	N/A
Completed	`NCT04042792` - Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
Recruiting	`NCT05554029` - Coronaphobia in Rheumatic Diseases	N/A
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Completed	`NCT02694796` - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy	N/A
Completed	`NCT02269254` - Persona Versus NexGen	N/A
Completed	`NCT02256098` - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA	N/A
Completed	`NCT00642837` - A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets	Phase 4
Active, not recruiting	`NCT04704544` - Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)	N/A
Completed	`NCT05026853` - Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice	N/A
Active, not recruiting	`NCT04631965` - Healthcare Transition of Adolescents With Chronic Health Conditions
Recruiting	`NCT00024479` - Natural History of Rheumatic Diseases in Minority Communities
Completed	`NCT05031104` - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis	N/A
Not yet recruiting	`NCT04567576` - Predictive Factors for COVID-19 in Rheumatology
Completed	`NCT02291471` - Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers	Phase 1
Completed	`NCT01227694` - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis	Phase 1/Phase 2
Recruiting	`NCT01071447` - Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment	N/A
Active, not recruiting	`NCT05618782` - Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee	Phase 2
Active, not recruiting	`NCT05543642` - The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)	Phase 4
Active, not recruiting	`NCT02694185` - Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications	N/A